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Abstract
Background: Increasing clinical epidemiological and experimental evidence indicates that excess
of production of reactive oxygen free radicals (ROS) induced by an oxidative stress is involved in
the pathogenesis of a number of human airway disorders, as well as equine recurrent airway
obstruction. Free-radicals modulate the activation of transcription factors, such as nuclear factor-
(NF)-κB and activator protein (AP)-1, in several different cells. This activation leads to expression
of many pro-inflammatory cytokines, including interleukin (IL)-1β. We have hypothesized that
equine airway sensitization might induce an oxidative stress and increase the ROS production,
which in turn might enhance a production of IL-1β and airway hyperresponsiveness.
Methods: We have examined the effect of passive sensitization on IL-1β mRNA expression and
electrical field stimulation (EFS)-induced contraction in equine isolated bronchi, and the potential
interference of reduced-glutathione (GSH), an antioxidant, with these responses. Bronchi passively
sensitized with serum from animals suffering from heaves and having high total level of IgE, and
control tissues, either pretreated or not with GSH (100 µM), were used to quantify IL-1β mRNA.
Other tissues were used to study the effect of EFS (3–10–25 Hz).
Results: Mean IL-1β mRNA expression was higher in passively sensitized than in control rings.
GSH significantly (p < 0.05) reduced the IL-1β mRNA expression only in passively sensitized
bronchi. ELF induced a frequency-dependent contraction in both non-sensitized and passively
sensitized tissues, with a significantly greater response always observed in sensitized tissues. GSH
did not modify the EFS-induced contraction in non-sensitized bronchi, but significantly (p < 0.05)
decreased it in passively sensitized tissues.
Conclusion:  Our data indicate that the passive sensitization of equine bronchi induces
inflammation and hyperresponsiveness. These effects might be due to an oxidative stress because
a pretreatment with GSH decreased the increased IL-1β mRNA expression and responsiveness to
EFS of passively sensitized bronchi.
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Introduction
Increasing clinical epidemiological and experimental evi-
dence indicates that excess of production of reactive oxy-
gen free radicals (ROS) is involved in the pathogenesis of
a number of airway disorders [1]. When airway cells and
tissues are exposed to oxidative stress elicited by environ-
mental pollutants, infections, antigen challenge, inflam-
matory reactions or decreased level of antioxidants, the
enhanced production of ROS can negatively affect several
chronic obstructive airway diseases, including human
asthma and COPD and equine recurrent airway obstruc-
tion (RAO) [2-4]. Horses suffering from RAO have a
decreased pulmonary antioxidant capacity, which may
render them more susceptible to oxidative challenge [5].
The importance of ROS in inducing RAO is documented
by the fact that isoprostanes, which are markers of lipid
peroxidation [7], are increased by pulmonary oxidative
stress induced by strenuous exercise in heaves-horses and,
moreover, epiPGF2α is significantly augmented in these
horses during an exacerbation and correlated with airway
inflammation and pulmonary function [8,9]. It must be
highlighted that experimental airway antigen challenge is
associated with immediate formation of ROS, which per-
sists throughout the late asthmatic response [10] and, at
least in rats, antigen exposure also increases lipid peroxi-
dation in bronchoalveolar lavage [6].
This resulting oxidative stress may lead to the induction of
redox-sensitive transcription factors such as nuclear factor
(NF)-κB, hypoxia inducible factor (HIF) and activator
protein (AP)-1 in several different cells that leads to an
increased expression of pro-inflammatory cytokines,
including interleukin (IL)-1β [11,12]. Interestingly, IL-1β
plays an autocrine role in altered responsiveness of atopic
asthmatic sensitized airway smooth muscle, at least in
humans [13].
High levels of NF-κB activity are found during crisis in
heaves-susceptible horses [14,15]. Therefore, it is not sur-
prising that exacerbation of the disease in heaves-suscep-
tible horses coincides with increased mRNA expression in
BAL cells of the pro-inflammatory cytokines IL-1β and
tumor necrosis factor (TNF)-α [16].
Airways that have been passively sensitized with serum
from atopic asthmatic patients can be used to study
pathophysiological mechanisms that underlie the induc-
tion of airway inflammation and hyperresponsiveness
[17,18].
We hypothesized that airway sensitization might induce
an oxidative stress and increase the ROS production,
which in turn might enhance a production of IL-1β and
airway hyperresponsiveness. Therefore, this study aimed
to evaluate the effect of passive sensitization on IL-1β
mRNA expression and on contraction induced by electri-
cal field stimulation (EFS) in equine isolated bronchi and
to explore the effect of an antioxidant, the reduced-glu-
tathione (GSH), on these responses.
Materials and methods
Tissue preparations
Four healthy equine male lungs (aged 1.7 ± 0.09 years;
weighted kg 390 ± 64.9) were obtained from local abat-
toir; all animals showed a negative history of heaves.
Immediately, after resection, 3rd generation bronchi were
excised, cleaned and cut in rings.
Passive sensitization
Tissues were passively sensitized in a random manner, as
described by Schmidt et al. [19]. Briefly, equine bronchial
smooth muscle rings were rotated overnight at room tem-
perature in tubes containing modified Krebs Henseleit
buffer (KH; composition in mM. 118.4 NaCl, 25.0
NaHCO3, 11.7 dextrose, 4.7 KCl, 2.6 CaCl2, 2H2O, 1.19
MgSO4·7H2O and 1.16 KH2PO4 with a cyclo-oxygenase
inhibitor; indomethacin; 5 µM; pH 7,4,) in the absence
(control rings) or presence of sensitizing serum (sensi-
tized rings). The serum was prepared from the whole
blood of animals suffering from heaves, during an exacer-
bation, with a total level of IgE of 8,095.04 ± 90.9, meas-
ured as described by Tizard [20]. Sera were not pooled but
were frozen at -20°C in 200-ml aliquots until required.
In order to evaluate the role of ROS in sensitized airways,
some of control tissues or sensitized ones were treated
with GSH (100 µM). The following morning rings were
transferred to 10 ml organ baths aerated with 5% CO2 and
95 O2%, at 37°C; containing modified KH buffer, which
was changed every 10 min. The isometric changes in ten-
sion were measured with a transducer Fort 10 WPI (Basile,
Instruments, Italy)
Lymphocyte proliferation assay
Lymphocyte proliferation assay was carried out in dupli-
cate wells of a 6 well flat bottomed plates (Costar, MA)
using horse peripheral blood mononucler cells (PBMCs).
For PBMC isolation, blood samples (10 ml) were col-
lected from a healthy horse; cells were then isolated using
the standard Ficoll-Hypaque method, and washed three
times in PBS. PBMCs were seeded by centrifugation and
suspended in RPMI 1640 medium (GIBCO) supple-
mented by 10% inactivated SFB, and antibiotics (penicil-
lin/ml 200 IU and 150 µg/ml streptomycin) at a final
concentration of 2 × 106 cells/ml. For lymphocyte stimu-
lation assays (LSAs), 1 ml of cell suspension along with
either 1 ml of ConA (extract from Concanavalia ensiformis,
ICN Biochemicals, Cleveland, Ohio, USA) at 10 µg/ml or
1 ml of medium alone were added to 6 well plates TheRespiratory Research 2005, 6:104 http://respiratory-research.com/content/6/1/104
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plates were incubated at 37°C and 5% CO2 for 18 or 24
hours. Duplicate cultures were set up to separately meas-
ure cytokine production and cellular proliferation. Total
RNA was isolated from either stimulated or non stimu-
lated PBMCs cultures using the RNeasy tissue kit (Qiagen
Inc., Valencia, CA, USA). RNA concentration was meas-
ured by optical density. RNA samples were treated with
amplification grade DNAse I (Amersham) to remove any
traces of genomic DNA. RT PCR was performed in order
to amplify IL1β mRNA using the specific primers FIL-1β
5'GAGGCAGCCATGGCAGCAGTA3' and RIL-1β
5'TGTGAGCAGGGAACGGGTATCTT3' that were
designed on the basis of the horse IL1β sequence pub-
lished in the GENBANK database (D42147). The RT PCR
was performed using the Reverse iTtm one step RT-PCR kit
(ABgene), briefly, RNA of each sample was reverse tran-
scribed at 47°C for 30' and then incubated at 95°C for 5'.
The resulting cDNA was amplified in 35 cycles of denatur-
ation at 94°C for 30 sec, annealing at 58°C for 30 sec and
extension at 72°C for 30 sec, followed by a final extension
step at 72°C for 7 min. The amplicons were subsequently
analyzed on a 1% agarose gel stained with ethidium bro-
mide using Fluor S Multimager (Biorad USA).
Standard DNA preparation
The specific fragment of 257 bp of horse IL1β gene previ-
ously amplified from ConA stimulated PBMCs was cloned
into the pCR 4/TOPO vector using TOPO cloning kit (Inv-
itrogen) and purified with Turbo Kit (QBIOgene). The
recombinant plasmid was linearized upstream the target
sequence using the restriction endonuclease PmeI (Fer-
mentas) to avoid the presence of supercoiled plasmid and
to simulate more closely the amplification efficiency of
genomic DNA. The linearized plasmid was visualized and
quantified by electrophoresis in 1% agarose gel contain-
ing ethidium bromide using 2-log DNA ladder (New Eng-
land BioLabs). 10-fold dilutions of the plasmid were
made representing 1,14 × 109 copies of DNA/µl of tem-
plate and stored at -80°C until required. The PCR stand-
ard curve was constructed by plotting the plasmid DNA
dilutions against the corresponding QPCR threshold cycle
value. The threshold was determined using the Auto-Find
Threshold function of the Rotor-Gene 3000 (Corbett
Research, AU) that scans the range of threshold levels to
obtain the best fit of the standard curve through the sam-
ples that have been defined as standards.
Expression of mRNA for IL-1β in equine isolated bronchi
RNA was extracted from all mucosal specimens by using
RNeasy tissue kit (QIAgen Inc., Valencia, CA, USA). The
total RNA was isolated and quantified by spectrophotom-
etry and the ratio 260/280 was estimated. The purified
mRNA was incubated for 30 minutes at 37°C with DNAse
I (Amersham Biosciences) to eliminate genomic DNA. 50
µg of mRNA was reverse transcribed at 37°C for 60' using
the Sensicript reverse transcriptase (Qiagen) and specific
reverse primer RIL-1β'. The resulting cDNA was then
amplified by real time PCR. The quantitative PCR assay
was developed to allow an absolute quantification of the
cDNA. The reaction was carried out on the Rotor-Gene
3000 system (Corbett Research, Australia), using Quanti-
Tect SYBR Green PCR kit (Qiagen). Each sample was
amplified in a final volume of 20 µl containing 10 µl of
master mix, 20 pmol of primers FIL1β and RIL1β and 5 µl
of cDNA. Cycling parameters were 15 min at 95°C for the
hot start TAQ polymerase activation followed by 45 cycles
of 15 s at 94°C, 20 s at 58°C and 20 s at 72°C. Fluores-
cence data acquisition was carried out at the end of each
PCR extension phase. The reaction was performed testing
the samples and 5 standard plasmid dilution in duplicate.
Electrical field stimulation studies (EFS)
Tissues were allowed to equilibrate passively for 90 min.
During equilibration (2 h) optimal passive tension was
determined by gentle stretching of tissue (≅2 mg). The tis-
sue responsiveness was assessed by acetylcholine (ACh)
100 µM; when the response reached a plateau, rings were
washed tree times and allowed to equilibrate for 30 min.
After full recovery of the tissues, EFS was performed by
placing tissues between two wire platinum electrodes,
connected to a stimulator 3165 multiplexing pulse
booster (Basile Instruments, Italy). Tissues were electri-
cally stimulated for 10 sec (10 V, 0.2 ms) by increasing
EFS frequencies (3–10–25 Hz). At the end of the experi-
ments, the wet weight of each tissue was determined.
Analysis of results
Contractile response are expressed as percentage of ACh
(100 µM) induced contraction. All values are presented as
mean ± SEM. All n values refer to the number of the lungs.
Statistical significance was assessed by multifactorial anal-
ysis of variance (ANOVA). In presence of a significant
overall ANOVA, whenever there was significance, the
Tukey's Multiple Comparision test was applied at the 5%
level for comparison of the means. A probably level of P <
0.05 was considered as significant for all tests. All data
analysis was performed using computer software (Graph-
Pad Prism, CA, USA
Drugs
The following drugs were used: acetylcholine (ACh),
indomethacin and GSH (Sigma, Chem. Co. St Louis,
MO).
Results
Baseline characteristics of the bronchial rings
There was no significant difference (P > 0.05) between
passively sensitized and non-sensitized bronchi in
absence or in presence of a treatment with GSH (100 µM)
in wet weight or contraction induced by ACh 100 µM
(table 1).Respiratory Research 2005, 6:104 http://respiratory-research.com/content/6/1/104
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Effect of passive sensitization and GSH on expression on 
mRNA for IL-1β
Mean IL-1β mRNA expression in equine passively sensi-
tized bronchi was higher when compared to the control
rings. A pretreatment with GSH did not modify the IL-1β
mRNA expression in non-sensitized bronchi, whereas it
significantly reduced the IL-β mRNA expression in pas-
sively sensitized ones (Figure 1 and 2).
Effect of passive sensitization and GSH on EFS responses
EFS induced a contraction, frequency dependent, in both
non-sensitized and passively sensitized tissues. The mag-
nitude of this contraction was significantly greater in
serum-sensitized tissues than in non-sensitized ones at
each frequency used. (figure 3). A pretreatment with GSH
did not modify the EFS induced contraction in non-sensi-
tized bronchi (figure 3). In passively sensitized equine
bronchial rings, a pretreatment with GSH (100 µM) sig-
nificantly (P < 0.05) decreased contraction at all frequen-
cies used compared to passively sensitized tissues (figure
3).
Discussion
It has been demonstrated that passive sensitization of iso-
lated airway smooth muscles increases the contractile
responses to several agonists, such as histamine and leu-
kotriene C4 [19]. This effect is independent of specific IgE
and appears to be related to some other factors associated
with serum containing high concentrations of total IgE
[17,19,21].
The increased reactivity of airways could be due to an
increased production of ROS, a term that includes various
oxygen free radicals (superoxide anions, hydroxyl radi-
cals, hydrogen peroxide, hypochlorous acid, peroxynitrite
and ozone) released from alveolar macrophages, neu-
trophils and eosinophils when exposed to oxidative stress
elicited by inflammatory reactions, infections, environ-
mental pollutants or antigen challenge [22]. In effect,
studies carried out in asthmatic patients have demon-
strated that antigen challenge enhances the production of
ROS. Leukocytes obtained from asthmatic patients gener-
ate more ROS compared to cells derived from control
subjects [23]. Also neutrophils and monocytes purified
from blood of asthmatic patients possess a higher propen-
sity to release ROS than cells obtained from controls [24].
Oxidative stress induced by IgE challenge leads to the acti-
vation of genes for many pro-inflammatory cytokines,
including IL-1β, which plays an important role in airway
hyperresponsiveness and this not only in man but likely
even in heaves [2,12,16,25-27].
In the present study, equine passively sensitized isolated
bronchi showed a greater expression of IL-1β mRNA than
non sensitized tissues. Our result fits with the in vitro doc-
umentation that oxidants cause the release of inflamma-
tory mediators such as TNF-α, IL-8 and IL-1-β [26,27].
This is a phenomen that has also been documented in
horses. In fact, Giguere et al. [16] demonstrated that the
IL-1β mRNA expression was significantly higher after
exposure to moldy hay in horses with heaves when
compared to values obtained during clinical remission or
in healthy controls in one out of two trials.
The sensitized bronchial rings revealed also an increase in
the contractile response induced by EFS, which might be
related to an altered neural functioning. In human iso-
lated airways, Ichinose et al. [28] demonstrated that the
Table 1: Wet weight and contraction induced by ACh (100 µM.) in equine non-sensitized (C) and passively sensitized isolated bronchi, 
in absence or in presence of a treatment with reduced-glutathione (G; 100 µM). All values are mean ± SEM of four samples
CC + GSS + G
Wet weight mg 285 ± 42.2 295 ± 39 285 ± 30.1 254 ± 27.6
ACh contraction (gr) 15.80 ± 3.4 13.70 ± 0.4 16.40 ± 0.9 13.20 ± 0.5
Effects of passive sensitization and reduced-glutathione (G;  100 µM) on IL-1β mRNA Figure 1
Effects of passive sensitization and reduced-glutathione (G; 
100 µM) on IL-1β mRNA. Values are mean ± SEM of four 
samples. C: control rings; S: passively sensitized rings. *P < 
0.05 C vs. S; #P < 0.05 C+G vs. S; §P < 0.05 S+G vs. S.
c c+g s s+g
0
250
500
750
1000
fg/ml
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incubation of bronchi with IgE enhanced cholinergic neu-
rotransmission via a M2 dysfunction, without affecting the
responses to exogenously applied ACh. This finding is
likely related to an indirect mechanism involving inflam-
matory cell-derived mediators, such as cytokines, and
ROS, which can indirectly influence contractile responses
related to an alteration of airway nerve function. An
increased cholinergic nerve-induced contraction induced
by chemical oxidants has been documented in rat tracheal
smooth muscle too [29]. On the other hand, ROS also
elicit a direct effect on airway smooth muscles, acting
either as contractant or relaxant agents. In vitro, it has been
documented that exposure of guinea pig tracheal tissues
to peroxynitrite and hypochlorous acid causes hyperre-
sponsiveness to histamine and substance P [30,31] and
that the oxidative stress increases the contraction of iso-
lated human airway smooth muscles [32]. In agreement
with these findings, our results demonstrated that passive
sensitization enhances cholinergic nerve-induced
contraction, without affecting contractile responses
induced by exogenous ACh in equine bronchial rings. In
contrast, they did not confirm the previous documenta-
tion of Olszewwski et al [33] that in equine trachea,
hydrogen peroxide reduced exogenous spasmogen-
induced contraction. This discrepancy can partially be
explained by the fact that in the study of Olszewski et al
[33] only single rather synergistic action of free-radicals in
the trachea was examined, whereas our findings have
been obtained on isolated bronchi.
In order to confirm the hypothesis that airways inflamma-
tion and hyperresponsiveness observed in equine pas-
sively sensitized bronchi could be related to an increased
production of ROS, we evaluated the effects of a
Electrophoresis of IL1b RT-PCR product Figure 2
Electrophoresis of IL1b RT-PCR product. Specific 257 bp fragments amplified from PBMCs after 18 and 24 hours stimulation 
with ConA (lane A and B), lane C no template control, lane M molecular weight marker 100 bp
MA B C
300
200
257Respiratory Research 2005, 6:104 http://respiratory-research.com/content/6/1/104
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pretreatment with GSH on either non-sensitized or pas-
sively sensitized bronchi. We observed that a pretreatment
with GSH significantly decreased the IL-1β mRNA expres-
sion and the contraction induced in passively sensitized
tissues, but did not show any effect in the non-sensitized
ones. In order to justify these different responses, we must
consider that under normal circumstances ROS are kept
under tight control by SOD enzymes [26]. In acute and
chronic inflammation, the production of ROS increases at
a rate that overwhelms the capacity of the endogenous
defense system to remove them [26]. Moreover, GSH is an
important component of the lung antioxidant defense
[27]. Therefore, a supplementation of this antioxidant
agent is necessary to protect lungs from oxidative stress
during acute or chronic inflammation. Anyway, there is
evidence that also other antioxidant agents, such as N-
acetyl-cysteine (NAC), block both in vitro and in vivo the
release of inflammatory mediators from epithelial cells
and macrophages by a mechanism involving intracellular
GSH and decreasing NF-κB activation [34].
In conclusion, our results indicate that passive sensitiza-
tion of equine bronchi induces airway inflammation and
hyperresponsiveness. These effects might be due to an oxi-
dative stress. In fact, the increased IL-1β mRNA expression
and responsiveness to EFS of passively sensitized bronchi
were decreased by a pretreatment with GSH, which is an
antioxidant agent. It is not a surprise that the increase in
IL-1β mRNA expression was linked to an increase in air-
way hyperresponsiveness. In fact, it has been documented
that pre-incubation of human isolated small bronchi with
IL-1β increased responsiveness to substance P [35] and,
moreover, this cytokine induced hyperresponsiveness in
sensitized Brown-Norway rats [36]. However, from our
study any proper relationship between the increase in IL-
1β mRNA expression and the in smooth muscle contrac-
tility cannot clearly been seen and we cannot denied that
GSH inhibited both in an independent manner. There-
fore, further studies will better explain this finding.
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